- Report
- March 2025
- 185 Pages
Global
From €4004EUR$4,500USD£3,457GBP
- Report
- March 2025
- 182 Pages
Global
From €4004EUR$4,500USD£3,457GBP
- Report
- February 2025
- 187 Pages
Global
From €4004EUR$4,500USD£3,457GBP
- Report
- February 2025
- 184 Pages
Global
From €4004EUR$4,500USD£3,457GBP
- Report
- February 2025
- 185 Pages
Global
From €4004EUR$4,500USD£3,457GBP
- Report
- January 2025
- 182 Pages
Global
From €4004EUR$4,500USD£3,457GBP
- Report
- January 2025
- 185 Pages
Global
From €4004EUR$4,500USD£3,457GBP
- Report
- January 2025
- 185 Pages
Global
From €4004EUR$4,500USD£3,457GBP
- Report
- November 2024
- 180 Pages
Global
From €4004EUR$4,500USD£3,457GBP
- Drug Pipelines
- April 2025
- 400 Pages
Global
From €4448EUR$5,000USD£3,841GBP
- Report
- May 2025
- 120 Pages
Global
From €4226EUR$4,750USD£3,649GBP
- Report
- December 2024
- 200 Pages
Global
From €3336EUR$3,750USD£2,881GBP
- Report
- December 2024
- 200 Pages
Global
From €3336EUR$3,750USD£2,881GBP
- Report
- December 2024
- 200 Pages
Global
From €3336EUR$3,750USD£2,881GBP
- Report
- October 2024
- 200 Pages
Global
From €3336EUR$3,750USD£2,881GBP
- Report
- June 2025
- 142 Pages
Global
From €2811EUR$3,160USD£2,428GBP
€3514EUR$3,950USD£3,035GBP
- Report
- July 2025
- 150 Pages
Global
From €3425EUR$3,850USD£2,958GBP
€4315EUR$4,850USD£3,726GBP
- Report
- April 2025
- 150 Pages
Global
From €3425EUR$3,850USD£2,958GBP
€4315EUR$4,850USD£3,726GBP
- Report
- March 2025
- 150 Pages
Global
From €3425EUR$3,850USD£2,958GBP
€4315EUR$4,850USD£3,726GBP
- Report
- March 2025
- 150 Pages
Global
From €3425EUR$3,850USD£2,958GBP
€4315EUR$4,850USD£3,726GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more